Literature DB >> 25511322

Adjunctive traditional Chinese medicine therapy for patients with chronic rhinosinusitis: a population-based study.

Hung-Rong Yen1, Mao-Feng Sun, Cheng-Li Lin, Fung-Chang Sung, Chen-Chi Wang, Kai-Li Liang.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is a chronic illness with a high prevalence worldwide. The purpose of this study was to investigate the characteristics of adjunctive traditional Chinese medicine (TCM) use in patients with CRS.
METHODS: Data were retrieved from a dataset made available by the Taiwan National Health Insurance Research Database (NHIRD) containing the medical records of 1,000,000 randomly sampled beneficiaries insured in the year 2000. Patients newly diagnosed with CRS in the year 2000 were enrolled, and their medical records during the period 2000 to 2011 were collected and analyzed.
RESULTS: A total of 14,806 CRS subjects were enrolled in this study: 10,512 were non-TCM users and 4294 were TCM users. TCM group had a significantly higher proportion of females, were younger, and a greater proportion lived in urban areas compared with the non-TCM group (all p < 0.0001). Ninety-seven percent (97%) of the TCM users received herbal remedies. The most common Chinese herbal formula used was Xin-Yi-Qing-Fei-Tang and the most commonly used single herb was Baizhi. The hazard ratio (HR) for functional endoscopic sinus surgery (FESS) was 0.17 for TCM users (95% confidence interval [CI], 0.15 to 0.20) compared with non-TCM users after adjusting for age, sex, urbanization, and comorbidities.
CONCLUSION: Our investigation found that 29% of CRS patients used TCM in addition to Western medical treatment. A lower proportion of patients in the TCM group underwent ESS compared with that in the non-TCM group. These findings may be of value in further studies evaluating the efficacy and safety of TCM use in CRS patients.
© 2014 ARS-AAOA, LLC.

Entities:  

Keywords:  acupuncture; chronic rhinosinusitis; complementary and alternative therapy; functional endoscopic sinus surgery; traditional Chinese medicine

Mesh:

Substances:

Year:  2014        PMID: 25511322     DOI: 10.1002/alr.21446

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  11 in total

1.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

2.  Shin'iseihaito (Xinyiqingfeitang) extract ameliorates ovalbumin-induced murine allergic rhinitis by regulating cytokines.

Authors:  Masaaki Minami; Toru Konishi; Hiroshi Takase; Toshiaki Makino
Journal:  J Nat Med       Date:  2021-11-18       Impact factor: 2.343

3.  Effect of Shin'iseihaito on murine allergic reaction induced by nasal sensitization.

Authors:  Masaaki Minami; Toru Konishi; Zhixia Jiang; Tetsuya Arai; Toshiaki Makino
Journal:  J Tradit Complement Med       Date:  2015-06-21

4.  Characteristics of Traditional Chinese Medicine Use in Pediatric Cancer Patients: A Nationwide, Retrospective, Taiwanese-Registry, Population-Based Study.

Authors:  Hung-Rong Yen; Wan-Yu Lai; Chih-Hsin Muo; Mao-Feng Sun
Journal:  Integr Cancer Ther       Date:  2016-07-12       Impact factor: 3.279

5.  Effect of Shin'iseihaito (Xinyiqingfeitang) on Acute Streptococcus pneumoniae Murine Sinusitis via Macrophage Activation.

Authors:  Masaaki Minami; Toru Konishi; Hiroshi Takase; Zhixia Jiang; Tetsuya Arai; Toshiaki Makino
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-20       Impact factor: 2.629

6.  Comparison between the Effects of Oral and Intramuscular Administration of Shin'iseihaito (Xinyiqingfeitang) in a Streptococcus pyogenes-Induced Murine Sinusitis Model.

Authors:  Masaaki Minami; Toru Konishi; Hiroshi Takase; Toshiaki Makino
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-02       Impact factor: 2.629

7.  Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study.

Authors:  Yi-Ting Kuo; Hou-Hsun Liao; Jen-Huai Chiang; Mei-Yao Wu; Bor-Chyuan Chen; Ching-Mao Chang; Ming-Hsien Yeh; Tung-Ti Chang; Mao-Feng Sun; Chia-Chou Yeh; Hung-Rong Yen
Journal:  Integr Cancer Ther       Date:  2017-08-03       Impact factor: 3.279

8.  Utilization of Chinese medicine for respiratory discomforts by patients with a medical history of tuberculosis in Taiwan.

Authors:  Su-Tso Yang; Yi-Rong Lin; Mei-Yao Wu; Jen-Huai Chiang; Pei-Shan Yang; Te-Chun Hsia; Hung-Rong Yen
Journal:  BMC Complement Altern Med       Date:  2018-11-29       Impact factor: 3.659

9.  Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study.

Authors:  Yi-Ting Kuo; Tung-Ti Chang; Chih-Hsin Muo; Mei-Yao Wu; Mao-Feng Sun; Chia-Chou Yeh; Hung-Rong Yen
Journal:  Integr Cancer Ther       Date:  2017-06-30       Impact factor: 3.279

10.  Complementary traditional Chinese medicine use in Children with cerebral palsy: a nationwide retrospective cohort study in Taiwan.

Authors:  Hou-Hsun Liao; Hung-Rong Yen; Chih-Hsin Muo; Yu-Chen Lee; Mei-Yao Wu; Li-Wei Chou; Mao-Feng Sun; Tung-Ti Chang
Journal:  BMC Complement Altern Med       Date:  2017-03-14       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.